Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Massari

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 19, 2024
Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medicationGiovanni Maconi, Federica Lepore, Adam Saleh, et al.
Inflammatory Bowel Diseases|July 23, 2013
Serum hepcidin in inflammatory bowel diseases: biological and clinical significanceGaetano Bergamaschi, Antonio Di Sabatino, Riccardo Albertini, et al.
The American Journal of Gastroenterology|July 23, 2009
Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawalAndrea Cassinotti, Giovanni C Actis, Piergiorgio Duca, et al.
Journal of Crohn'S & Colitis|March 24, 2017
The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre StudyLaura Cantoro, Antonio Di Sabatino, Claudio Papi, et al.
United European Gastroenterology Journal|November 9, 2019
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis: A real-life experienceGiovanni Maconi, Nicolò Mezzina, Stefano Landi, et al.
Haematologica|October 10, 2009
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatmentGaetano Bergamaschi, Antonio Di Sabatino, Riccardo Albertini, et al.
Thrombosis and Haemostasis|June 17, 2016
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatmentAntonio Di Sabatino, Francesca Santilli, Marco Guerci, et al.
Inflammatory Bowel Diseases|September 18, 2010
Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's diseaseAntonio Di Sabatino, Paolo Biancheri, Silvia Piconese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 20, 2018
Totally laparoscopic, multi-stage, restorative proctocolectomy for inflammatory bowel diseases. A prospective study on safety, efficacy and long-term resultsGianluca M Sampietro, Francesco Colombo, Alice Frontali, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 23, 2021
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control populationGiovanni Maconi, Cristina Bosetti, Alberta De Monti, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 19, 2024
Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medicationGiovanni Maconi, Federica Lepore, Adam Saleh, et al.
Inflammatory Bowel Diseases|July 23, 2013
Serum hepcidin in inflammatory bowel diseases: biological and clinical significanceGaetano Bergamaschi, Antonio Di Sabatino, Riccardo Albertini, et al.
The American Journal of Gastroenterology|July 23, 2009
Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawalAndrea Cassinotti, Giovanni C Actis, Piergiorgio Duca, et al.
Journal of Crohn'S & Colitis|March 24, 2017
The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre StudyLaura Cantoro, Antonio Di Sabatino, Claudio Papi, et al.
United European Gastroenterology Journal|November 9, 2019
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis: A real-life experienceGiovanni Maconi, Nicolò Mezzina, Stefano Landi, et al.
Haematologica|October 10, 2009
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatmentGaetano Bergamaschi, Antonio Di Sabatino, Riccardo Albertini, et al.
Thrombosis and Haemostasis|June 17, 2016
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatmentAntonio Di Sabatino, Francesca Santilli, Marco Guerci, et al.
Inflammatory Bowel Diseases|September 18, 2010
Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's diseaseAntonio Di Sabatino, Paolo Biancheri, Silvia Piconese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 20, 2018
Totally laparoscopic, multi-stage, restorative proctocolectomy for inflammatory bowel diseases. A prospective study on safety, efficacy and long-term resultsGianluca M Sampietro, Francesco Colombo, Alice Frontali, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 23, 2021
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control populationGiovanni Maconi, Cristina Bosetti, Alberta De Monti, et al.
Pageof 3